Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI could make radiation therapy more precise by tracking tumors without markers

NCT ID NCT05184790

First seen May 19, 2026 · Last updated Jun 22, 2026 · Updated 4 times

Summary

This study is developing an artificial intelligence system that can track the movement of tumors and nearby organs during radiation therapy without needing implanted markers. Researchers will use data from 300 patients receiving radiation for various cancers or heart arrhythmias to train and test the AI. The goal is to enable real-time image guidance to improve treatment accuracy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alfred Health

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3000, Australia

    Contact Email: •••••@•••••

  • Peter MacCallum Cancer Centre

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3000, Australia

    Contact Email: •••••@•••••

  • Princess Alexandra Hospital

    NOT_YET_RECRUITING

    Woolloongabba, Queensland, 4102, Australia

    Contact Email: •••••@•••••

  • Royal North Shore Hospital

    RECRUITING

    Saint Leonards, New South Wales, 2065, Australia

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to more precise radiation therapy by tracking tumors in real time without needing implanted markers.

What could go wrong

This is an early-stage observational study that does not test a treatment. The AI method may not prove accurate enough for clinical use, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac brain cancer breast neoplasm cardiac rhythm disease Head and Neck Neoplasms kidney cancer Liver Neoplasms pancreatic neoplasm prostate cancer Spinal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.